Singapore markets closed

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5415-0.0208 (-3.70%)
At close: 04:00PM EDT
0.5500 +0.01 (+1.57%)
After hours: 06:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
7,587
7,587
19,836
4,690
4,390
Selling general and administrative
5,361
5,361
6,910
18,712
1,155
Total operating expenses
10,718
10,718
24,222
19,870
1,613
Operating income or loss
-10,718
-10,718
-24,222
-19,870
-1,613
Interest expense
353.945
353.945
109.525
1,295
995.496
Total other income/expenses net
445.857
445.857
1,262
-6,060
2,448
Income before tax
-10,626
-10,626
-24,208
-29,146
-160.875
Income from continuing operations
-10,626
-10,626
-24,208
-29,146
-160.875
Net income
-10,613
-10,613
-24,172
-29,084
56.77
Net income available to common shareholders
-10,626
-10,626
-25,085
-29,887
56.77
Basic EPS
-1.86
-
-139.42
-355.68
0.56
Diluted EPS
-1.86
-
-139.42
-355.68
0.56
Basic average shares
1,685
-
179.925
84.018
101.148
Diluted average shares
1,685
-
179.925
84.018
101.148